Monoamine oxidases (MAO) are a family of mitochondrial enzymes that catalyze the oxidative deamination of monoamines. Two isoforms of MAO exist, MAO-A and MAO-B, with different inhibitor selectivity and tissue distribution. MAO dysfunction is thought to be responsible for a number of neurological disorders. Unusually high or low levels of MAOs in the body have been associated with depression, schizophrenia, substance abuse, attention deficit disorder, migraines, and irregular sexual maturation. MAO inhibitors are one of the major classes of drug prescribed for the treatment of depression, Parkinson′s, and Alzheimer′s diseases.
Features and Benefits
Compatible with high-throughput handling systems.
Suitability
The kit is suitable for inhibitor screening and evaluation of MAO inhibitors.
Principle
The Monoamine Oxidase (MAO) Inhibitor Screening Kit provides a convenient fluorometric means to screen for MAO enzyme inhibitors. In the assay, MAO reacts with p-tyramine, a substrate for both MAO-A and MAO-B, resulting in the formation of H2O2, which is determined by a fluorometric method at λEx = 530 nm/λEm = 585 nm.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.